Lexeo Therapeutics (LXEO) Interest & Investment Income (2022 - 2026)

Lexeo Therapeutics' Interest & Investment Income history runs 5 years deep, the most recent figure standing at $2.1 million for Q1 2026.

• In Q1 2026, Interest & Investment Income rose 77.12% year-over-year to $2.1 million; the TTM figure through Mar 2026 stood at $7.0 million (down 0.68% YoY), while the FY2025 annual figure was $6.1 million, down 18.87% from the prior year.
• Interest & Investment Income came in at $2.1 million for Q1 2026 at Lexeo Therapeutics, down from $2.2 million in the prior quarter.
• In the past five years, Interest & Investment Income ranged from a high of $2.3 million in Q2 2024 to a low of $456000.0 in Q3 2022.
• A 5-year average of $1.3 million and a median of $1.3 million in 2025 frame the typical range for Interest & Investment Income.
• Across the five-year window, Interest & Investment Income surged 328.69% in 2024 and tumbled 46.0% in 2025, its largest moves.
• Lexeo Therapeutics' Interest & Investment Income stood at $676000.0 in 2022, then soared by 63.02% to $1.1 million in 2023, then jumped by 32.94% to $1.5 million in 2024, then jumped by 51.06% to $2.2 million in 2025, then declined by 4.52% to $2.1 million in 2026.
• According to Business Quant data, Interest & Investment Income over the past three periods registered $2.1 million, $2.2 million, and $1.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison